We are live on ! Find out more
FNBT

FineMark National Bank & Trust Portfolio holdings

AUM $3.2B
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+18.28%
3 Year Est. Return
+69.81%
5 Year Est. Return
+87.67%
10 Year Est. Return
+274.39%
AUM
$837M
AUM Growth
+$95.9M
Cap. Flow
+$54.3M
Cap. Flow %
6.48%
Top 10 Hldgs %
23.93%
Holding
1,582
New
69
Increased
371
Reduced
363
Closed
244

Top Sells

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$3.96M
2
NVS icon
Novartis
NVS
+$2.92M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.38M
4
BUD icon
AB InBev
BUD
+$2.25M
5
SNY icon
Sanofi
SNY
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 11.82%
2 Financials 11.38%
3 Industrials 11.03%
4 Technology 10.89%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTG icon
701
Entegris
ENTG
$24.6B
$34K ﹤0.01%
2,585
FTNT icon
702
Fortinet
FTNT
$118B
$34K ﹤0.01%
5,525
-820
-13% -$5.89K
IYE icon
703
iShares US Energy ETF
IYE
$1.8B
$34K ﹤0.01%
+1,000
New +$37K
JBLU icon
704
JetBlue
JBLU
$2.18B
$34K ﹤0.01%
1,522
OPLN
705
Openlane
OPLN
$4.34B
$34K ﹤0.01%
2,402
+117
+5% +$1.66K
KMPR icon
706
Kemper
KMPR
$1.56B
$34K ﹤0.01%
920
PSMT icon
707
Pricesmart
PSMT
$5.49B
$34K ﹤0.01%
410
TNL icon
708
Travel + Leisure Co
TNL
$4.58B
$34K ﹤0.01%
1,034
UTHR icon
709
United Therapeutics
UTHR
$21.9B
$34K ﹤0.01%
217
XHB icon
710
State Street SPDR S&P Homebuilders ETF
XHB
$1.58B
$34K ﹤0.01%
1,000
RVNC
711
DELISTED
Revance Therapeutics, Inc.
RVNC
$34K ﹤0.01%
1,000
-1,000
-50% -$34.7K
TFCFA
712
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$34K ﹤0.01%
1,244
HSNI
713
DELISTED
HSN, Inc.
HSNI
$34K ﹤0.01%
675
+56
+9% +$3.05K
HRI icon
714
Herc Holdings
HRI
$5.63B
$33K ﹤0.01%
759
+71
+10% +$3.56K
IIM icon
715
Invesco Value Municipal Income Trust
IIM
$598M
$33K ﹤0.01%
2,000
+500
+33% +$7.91K
KLAC icon
716
KLA
KLAC
$272B
$33K ﹤0.01%
4,750
AMSC icon
717
American Superconductor
AMSC
$1.56B
$32K ﹤0.01%
5,000
ENTA icon
718
Enanta Pharmaceuticals
ENTA
$393M
$32K ﹤0.01%
973
XRAY icon
719
Dentsply Sirona
XRAY
$2.27B
$32K ﹤0.01%
521
-4
-0.8% -$238
CCMP
720
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$32K ﹤0.01%
742
-885
-54% -$37.3K
EXAM
721
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$32K ﹤0.01%
1,198
+7
+0.6% +$189
NFLX icon
722
Netflix
NFLX
$309B
$31K ﹤0.01%
2,750
-2,950
-52% -$33.7K
PZA icon
723
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.27B
$31K ﹤0.01%
1,200
SLGN icon
724
Silgan Holdings
SLGN
$4.3B
$31K ﹤0.01%
1,170
SSYS icon
725
Stratasys
SSYS
$767M
$31K ﹤0.01%
1,310
-324
-20% -$8.53K

Similar funds

FineMark National Bank & Trust's Q4 2015 Portfolio in Review

As of Q4 2015, FineMark National Bank & Trust held 1,582 positions worth $837M, up 13% from $741M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

FineMark National Bank & Trust deployed $54.3M of net new capital in Q4 2015, opening 69 new positions and adding to 371 existing holdings. Its largest new stake was Alphabet (Google) Class C: 256,360 shares worth $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Phillips 66, an estimated $3.96M trimmed.

  • FineMark National Bank & Trust's largest Q4 2015 buy was Alphabet (Google) Class C: 256,360 shares worth $9.73M.
  • FineMark National Bank & Trust added most to iShares Russell 2000 ETF in Q4 2015, an estimated $6.76M increase.
  • FineMark National Bank & Trust's biggest Q4 2015 reduction was Phillips 66, cutting an estimated $3.96M.
  • FineMark National Bank & Trust fully exited Novartis in Q4 2015, selling an estimated $2.92M.
  • FineMark National Bank & Trust's ten largest holdings make up 24% of its $837M portfolio in Q4 2015.
  • FineMark National Bank & Trust opened 69 new positions and closed 244 in Q4 2015.
  • FineMark National Bank & Trust's portfolio value rose 13% quarter-over-quarter to $837M.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.